title: [Eating my hat?].
abstract: After clearing many hurdles, gene therapy is now reaching the commercialization stage and can be expected to make a modest but real contribution to treatment in the near future.
authors.affiliation: CoReBio PACA, case 901, parc scientifique de Luminy, 13288 Marseille Cedex 9, France.
authors.forename: Bertrand
authors.initials: B
authors.lastname: Jordan
mesh_terms: D035843:Biomedical Research / Q000191:economics / Q000639:trends; D002986:Clinical Trials as Topic; D003132:Commerce; D015316:Genetic Therapy / Q000191:economics* / Q000639:trends*; D006467:Hemophilia A / Q000453:epidemiology / Q000235:genetics / Q000628:therapy; D006801:Humans; D008072:Hyperlipoproteinemia Type I / Q000453:epidemiology / Q000235:genetics / Q000628:therapy; D057130:Leber Congenital Amaurosis / Q000453:epidemiology / Q000235:genetics / Q000628:therapy; D012174:Retinitis Pigmentosa / Q000453:epidemiology / Q000235:genetics / Q000628:therapy; D016896:Treatment Outcome